Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders

Tom Doetschman, Marcia Shull, Ann Kier, J. Douglas Coffin

Research output: Contribution to journalArticle

45 Scopus citations

Abstract

To better understand the formation of the cardiovascular system and its disease states, models amenable to manipulation must be developed. In this article we present two models. One is a small animal model for an inflammatory disorder that can lead to heart failure. Production of this model is based on the ability of blastocyst-derived embryonic stem cells, which can be genetically altered in vitro by a technique called gene targeting, to reconstitute an entire animal when reintroduced into a blastocyst and allowed to colonize the germ line of the resulting chimeric embryo. The other model is based on the capacity of embryonic stem cells to differentiate in culture into embryo-like structures called embryoid bodies. Embryoid bodies contain angioblasts, or prevascular endothelial cells, which can be induced to undergo aspects of vascular development by manipulation of culture conditions.

Original languageEnglish (US)
Pages (from-to)618-629
Number of pages12
JournalHypertension
Volume22
Issue number4
DOIs
StatePublished - Oct 1993
Externally publishedYes

Keywords

  • Angiogenesis
  • Embryonic stem cells
  • Fibroblast growth factor
  • Myocarditis
  • Transfection
  • Transforming growth factor beta
  • Vasculogenesis

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders'. Together they form a unique fingerprint.

  • Cite this